Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • zhoufan
    Member
    • Feb 2009
    • 14

    #16
    Hi,
    I am trying Jelly 13.10.22 version on ubuntu 10.04 with smrtanalysis 2.0.1 . I am trying the sample data and the support stage have no result with no error. Has anyone met this kind of situation?

    Comment

    • HenrivdGeest
      Member
      • Feb 2012
      • 16

      #17
      Yes,I also encounter this.
      I think there is a small bug in the sample scripts in the latest release of pbjelly(13.10.22). The mapping quality of the reads is lower than the default filtering settings of the support stage. If you run the support stage with lower settings it should work:
      Jelly.py support Protocol.xml -x "--minMapqv=45" # the qv of mapped reads in the sample = 50.
      ( I got this more or less from the documentation from the pbjelly website at sourceforge)

      Comment

      • bio_d
        Junior Member
        • Oct 2017
        • 6

        #18
        Running PBJELLY on SLURM

        How do I submit PBJELLY script in a cluster(SLURM)?

        I mean slurm doesn't allow job submission at head node whereas PBJELLY says the script will itself submit jobs according to the specifications in the <cluster></cluster> tag of the Protocol.xml file.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        29 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        212 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        78 views
        0 reactions
        Last Post SEQadmin2  
        Working...